Additionally, our colleagues’ previous study revealed that ARNTL exhibited low expression in NPC and inhibited tumorigenesis and cisplatin resistance by targeting CDK5, but did not affect cell migration and invasion abilities [15]. Here, BMAL1 is linked to nasopharyngeal carcinoma.